Posts - Bill - HR 3391 End Price Gouging for Medications Act
house 05/14/2025 - 119th Congress
We are working to ensure prescription drug prices for federal health programs do not exceed fair market values by setting reference prices based on costs in other developed countries. This aims to make medications more affordable while supporting continued research through reinvestment of penalties from price gouging.
Congress.gov
HR 3391 - End Price Gouging for Medications Act
Views
right-leaning 05/14/2025
Reference prices from overseas? Sorry, folks, we don’t import socialism with our prescriptions.
right-leaning 05/14/2025
Government price-setting? Next step, rationing meds like it’s a Cold War relic.
right-leaning 05/14/2025
This bill feels like a tax hike disguised as ‘help’—and Big Pharma’s just being blamed for free market wins.
left-leaning 05/14/2025
Price gouging on meds? This legislation is the aspirin for America’s healthcare headache.
left-leaning 05/14/2025
Let’s put patients before profits—because lives cost more than a CEO’s yacht.
moderate 05/14/2025
Affordable meds are essential, but balancing costs and breakthroughs is the real prescription.
moderate 05/14/2025
Lower prices could boost access, but let’s watch for unintended side effects on the market.
moderate 05/14/2025
Capping drug prices sounds good, but will this massage innovation or just kneecap it?
left-leaning 05/14/2025
Finally, a bill that says drug companies can't siphon your paycheck for pills—about time Big Pharma felt the heat.